It has been reported that the MEFV gene mutations can be a risk for rheumatic diseases such as AOSD [37] and BD [38], and can modify clinical phenotypes of rheumatic diseases such as RA [39] and SLE [40]. This evidence concerns the gene MEFV and systemic lupus erythematosus.